CSIMarket
 


Quoin Pharmaceuticals Ltd   (QNRX)
Other Ticker:  
 

Cumulative Quoin Pharmaceuticals Ltd 's Leverage Ratio for Trailing Twelve Months Period

QNRX's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

QNRX Leverage Ratio for Trailing Twelve Months Period

(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity Growth -23.53 % 1028.36 % 1280.74 % 1561.17 % 1027.31 %
Y / Y Total Liabilities Growth -7.74 % -32.31 % -32.46 % -43.49 % -37.65 %
Leverage Ratio for Trailing Twelve Months Period 0.85 0.83 1.15 1.84 4.37
Total Ranking # 973 # 1537 # 1993 # 2608 # 3874
Seq. Equity Growth -23.6 % -18.28 % -16.88 % 47.36 % 1027.31 %
Seq. Total Liabilities Growth -15.01 % 0.22 % 19.52 % -9.38 % -37.65 %


Leverage Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Dec 31 2023
On the trailing twelve months basis Despite debt repayement of -15.01% in IV. Quarter, Leverage Ratio for Trailing Twelve Months Period improved to 0.85, below Quoin Pharmaceuticals Ltd 's average Leverage Ratio for Trailing Twelve Months Period.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Medical Equipment & Supplies industry 80 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Quoin Pharmaceuticals Ltd . While total ranking remained unchanged compare to previous quarter at no. .

What is Leverage Ratio?
Who are QNRX's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 81
Sector # 294
S&P 500 # 1207


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
13.24 1.77 0.31
(Dec 31 2021)   (Dec 31 2020)




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Dec 31 2023, within Medical Equipment & Supplies Industry Leverage Ratio for Trailing Twelve Months Period
Pear Therapeutics Inc   2.11 
Minerva Surgical Inc   2.11 
Escalon Medical Corp   1.92 
Vaso Corporation  1.89 
Conmed Corporation  1.87 
Therapeutic Solutions International Inc   1.81 
Artivion Inc   1.76 
Patterson Companies Inc   1.70 
Dexcom Inc   1.68 
Novocure Limited  1.67 
Iridex Corp  1.62 
Strata Skin Sciences Inc   1.59 
Tandem Diabetes Care Inc   1.59 
Msa Safety Incorporated  1.53 
Reshape Lifesciences Inc   1.44 
Transmedics Group Inc   1.43 
U S Physical Therapy Inc  1.42 
Neuronetics inc   1.34 
Soleno Therapeutics Inc  1.34 
Masimo Corp  1.33 
Tenon Medical Inc   1.32 
Helius Medical Technologies inc   1.31 
Nuvasive Inc  1.31 
Cadre Holdings Inc   1.26 
Lucid Diagnostics Inc   1.23 
Intelligent Bio Solutions Inc   1.23 
Haemonetics Corporation  1.20 
Stryker Corp  1.20 
Stereotaxis Inc   1.20 
Zynex inc   1.16 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com